FMP
Evolus, Inc.
EOLS
NASDAQ
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
11.5 USD
-0.2 (-1.74%)
About
ceo
Mr. David Moatazedi
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.evolus.com
exchange
NASDAQ
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
CIK
0001570562
ISIN
US30052C1071
CUSIP
30052C107
Address
520 Newport Center Drive
Phone
949 284 4555
Country
US
Employee
273
IPO Date
Feb 8, 2018
Key Executives
